You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Philippines Patent: 12021550882


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12021550882

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,400,077 Oct 25, 2039 Famygen Life Sci RYZUMVI phentolamine mesylate
12,201,615 Dec 25, 2039 Famygen Life Sci RYZUMVI phentolamine mesylate
12,201,616 Oct 25, 2039 Famygen Life Sci RYZUMVI phentolamine mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Philippines Patent PH12021550882

Last updated: August 15, 2025


Introduction

Patent PH12021550882, issued in the Philippines, pertains to a specific pharmaceutical invention, with a focus on its claims, scope, and the broader patent landscape. Understanding its parameters is vital for stakeholders, including pharmaceutical companies, generic drug manufacturers, and legal professionals, by providing clarity on patent rights, potential infringement issues, and opportunities for innovation. This analysis provides a comprehensive review of the patent’s scope and claims and maps its position within the Philippine and global pharmaceutical patent landscape.


Patent Overview

Patent Number: PH12021550882
Issue Date: [Insert issue date if known]
Application Filing Date: [Insert filing date if available]
Applicant/Owner: [Insert applicant/applicant information, if available]]

This patent likely covers a novel pharmaceutical composition, a process of manufacturing, or a specific formulation. However, without access to the full patent document in this context, technical synthesis is based on typical patent structures and available data.


Scope and Claims Analysis

1. Claims Structure

Claims define the legal boundaries of the patent’s protection. They can be independent or dependent, with independent claims describing the core invention broadly, while dependent claims specify particular embodiments.

In PH12021550882, the claims are presumed to encompass:

  • Composition Claims: Covering a specific drug formulation, including active pharmaceutical ingredients (APIs), excipients, and their ratios.
  • Method Claims: Detailing a novel manufacturing process, purification methods, or delivery mechanisms.
  • Use Claims: Claiming the therapeutic use of the formulation for particular indications.

The scope of protection hinges on the wording precision—broad claims cast a wider net but risk infringement challenges, whereas narrow claims offer specific protection but may be easier to design around.

2. Type and Breadth of Claims

  • Composition Claims: Likely specify an innovative combination of APIs that results in improved efficacy or reduced side effects.
  • Method Claims: Could illustrate a new synthesis or formulation process increasing yield or stability.
  • Use Claims: May protect novel therapeutic applications beyond existing indications.

Given the typical strategic scope of pharmaceutical patents in the Philippines, the claims aim to secure exclusive rights over the composition, manufacturing process, and therapeutic application.

3. Claim Novelty and Inventive Step

Assessing claims' novelty involves comparing them against prior art—existing pharmaceutical patents, publications, or formulations in the Philippines and globally.

  • Novelty: If the claims feature a unique combination or innovative mechanism, they are likely considered novel.
  • Inventive Step: Achieved if the invention demonstrates non-obvious improvements over existing technologies, such as increased bioavailability or targeted delivery.

The patent’s claims probably leverage substantial inventive steps rooted in innovative pharmacological properties or manufacturing techniques, aligning with requirements under Philippine patent law.


Patent Landscape in the Philippines

1. Local Patent Environment

The Philippine Intellectual Property Office (IPOPHL) oversees pharmaceutical patents, with strict adherence to the Philippines’ patent law aligned with the TRIPS Agreement. The country maintains a relatively straightforward pathway for patent registration, emphasizing novelty, inventive step, and industrial applicability.

Key points:

  • Pharmaceutical patents are enforceable for 20 years from the filing date.
  • Patentability may be challenged based on prior art, particularly for incremental inventions.
  • Compulsory licensing provisions enable third-party manufacturing under specific circumstances, affecting patent enforceability.

2. Existing Patent Landscape

The Philippine patent landscape for pharmaceuticals features several active players, including local innovators and international pharmaceutical firms.

  • Prevalent Patent Types: Most patents in the Philippines relate to formulations, delivery mechanisms, and manufacturing processes for drugs such as antiretrovirals, antihypertensives, antidiabetics, and biologics.
  • Patent Families: Many local patents are part of international patent families filed under the Patent Cooperation Treaty (PCT), providing regional coverage and legal robustness.
  • Patent Challenges and Litigation: While relatively few disputes are reported, compulsory licensing threats are periodically raised, especially for essential medicines.

Specific to PH12021550882, its scope may intersect with existing patents on similar formulations or active ingredients, creating potential for workarounds or licensing agreements.

3. Global Patent Landscape

The patent landscape expands beyond the Philippines, with major filings in jurisdictions like the US, Europe, and China. Corresponding patent families may protect the same invention globally, influencing the scope of unauthorized manufacture or importation in the Philippines.

Understanding these global patents allows stakeholders to:

  • Evaluate patent strength and enforceability.
  • Develop patent strategies aligned with international filings.
  • Identify potential infringement risks or freedom-to-operate opportunities.

Critical Considerations in Scope and Claims

  • Claim Breadth: Broad claims may provide extensive protection but can be vulnerable to validity challenges based on prior art.
  • Patent Validity: The claims must meet Philippine patentability standards—novelty, inventive step, and industrial applicability.
  • Potential Overlaps: Intersection with existing patents (local and international) could threaten the patent’s enforceability unless uniquely characterized.
  • Life Cycle: As the patent nears expiry, generics can enter the market, but patent term extensions or supplementary protection certificates (if applicable) can prolong exclusivity.

Legal and Commercial Implications

  • The scope of the patent significantly influences commercial strategy, licensing potential, and market exclusivity.
  • Narrow claims permit easier licensing and reduce infringement risks but limit market control.
  • Broad claims secure competitive advantages but require robust validity to withstand legal scrutiny.

Conclusion

The key to leveraging PH12021550882 effectively involves understanding its scope—centered on the specific formulation, process, or use—and how it fits into the Philippine and global patent landscape. Clear, well-defined claims that align with innovative advancements in pharmaceutical science will reinforce patent strength. Meanwhile, comprehensive landscape analysis aids in identifying pathways for licensing, avoiding infringement, or preparing for generic competition post-expiry.


Key Takeaways

  • Claims Specificity is Critical: Precise claims ensure enforceability and clear boundaries against competitors.
  • Patent Landscape Maps Risks and Opportunities: Understanding existing patents guides strategic decisions, including licensing and R&D directions.
  • Global Patent Consistency: International filings can protect the invention beyond the Philippines, providing broader market exclusivity.
  • Patent Life Cycle Management: Monitoring patent validity, potential challenges, and expiry dates influences commercialization strategies.
  • Legal Vigilance: Staying updated on local patent laws and international agreements ensures robust protection and freedom to operate.

FAQs

1. What is the typical duration of a pharmaceutical patent in the Philippines?
Patents are granted for 20 years from the filing date, subject to maintenance fees.

2. How does the scope of claims affect patent enforceability?
Broader claims can provide extensive protection but are more susceptible to invalidation; narrower claims are easier to defend but limit scope.

3. Can a patent be challenged or revoked in the Philippines?
Yes, through legal procedures like opposition or invalidation based on prior art or non-compliance with patentability criteria.

4. How does Philippine patent law handle incremental innovations?
Incremental innovations may be patentable if they demonstrate a sufficient inventive step and industrial applicability, but often face scrutiny.

5. What is the significance of the patent landscape in global pharmaceutical markets?
It informs strategic decisions on filing, licensing, infringement risk assessment, and market entry timing.


References:
[1] Philippines Intellectual Property Code (RA 8293)
[2] IPOPHL Patent Examination Guidelines
[3] WIPO Patent Landscape Reports (where applicable for comparative analysis)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.